FI914298A0 - Monoklonala motkroppar foer metall- katjoner och smao molekyler. - Google Patents

Monoklonala motkroppar foer metall- katjoner och smao molekyler.

Info

Publication number
FI914298A0
FI914298A0 FI914298A FI914298A FI914298A0 FI 914298 A0 FI914298 A0 FI 914298A0 FI 914298 A FI914298 A FI 914298A FI 914298 A FI914298 A FI 914298A FI 914298 A0 FI914298 A0 FI 914298A0
Authority
FI
Finland
Prior art keywords
motkroppar
monoklonala
molekyler
katjoner
smao
Prior art date
Application number
FI914298A
Other languages
English (en)
Other versions
FI100472B (fi
Inventor
Fred W Wagner
Dwane E Wylie
Sheldon M Schuster
Thomas R Coolidge
Pill-Soon Song
William Parker
Original Assignee
Univ Nebraska
Bionebraska Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23263379&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI914298(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Nebraska, Bionebraska Inc filed Critical Univ Nebraska
Publication of FI914298A0 publication Critical patent/FI914298A0/fi
Application granted granted Critical
Publication of FI100472B publication Critical patent/FI100472B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI914298A 1989-03-14 1991-09-12 Monoklonaalisia vasta-aineita metallikationeille FI100472B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32439289A 1989-03-14 1989-03-14
US32439289 1989-03-14
US9001401 1990-03-14
PCT/US1990/001401 WO1990010709A2 (en) 1989-03-14 1990-03-14 Monoclonal antibodies for metallic cations on small molecules

Publications (2)

Publication Number Publication Date
FI914298A0 true FI914298A0 (fi) 1991-09-12
FI100472B FI100472B (fi) 1997-12-15

Family

ID=23263379

Family Applications (1)

Application Number Title Priority Date Filing Date
FI914298A FI100472B (fi) 1989-03-14 1991-09-12 Monoklonaalisia vasta-aineita metallikationeille

Country Status (9)

Country Link
US (1) US5503987A (fi)
EP (2) EP0463110B1 (fi)
JP (1) JPH05504464A (fi)
AT (1) ATE161852T1 (fi)
AU (1) AU648022B2 (fi)
CA (1) CA2047717C (fi)
DE (1) DE69031909T2 (fi)
FI (1) FI100472B (fi)
WO (1) WO1990010709A2 (fi)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972656A (en) * 1989-03-14 1999-10-26 Bionebraska, Inc. Mercury binding polypeptides and nucleotides coding therefore
DE4007079A1 (de) * 1990-03-07 1991-09-12 Behringwerke Ag Monoklonale antikoerper gegen komplexierte und nicht komplexierte komplexbildner zur entfernung von schwermetallen aus waessrigen loesungen
AU8499691A (en) * 1990-09-05 1992-03-30 Neurex Corporation Method and composition for detecting bioactive peptides
US5273909A (en) * 1991-06-03 1993-12-28 Quantix Systems, L.P. Immunoassay for the detection of small aliphatic organic compounds
US5532136A (en) * 1993-06-22 1996-07-02 Bionebraska, Inc. Monoclonal antibody assay and kit for detecting metal cations in body fluids
US5459040A (en) * 1993-11-22 1995-10-17 The Regents Of The University Of California Enzyme amplified, complex linked, competitive and non-competitive assays for the detection of metal ions
US5476939A (en) * 1993-12-30 1995-12-19 Abbott Laboratories Certain pyridyl and isoquinolyl carbinolamine derivatives
AU1695795A (en) * 1994-01-27 1995-08-15 Bionebraska, Inc. Mercury binding polypeptides and nucleotides coding therefor
US6111079A (en) * 1995-06-05 2000-08-29 Bionebraska, Inc. Lead binding polypeptides and nucleotides coding therefore
WO1996039518A1 (en) * 1995-06-05 1996-12-12 Bionebraska, Inc. Lead binding polypeptides and nucleotides coding therefor
US5817527A (en) * 1995-11-06 1998-10-06 Chiron Diagnostics Corporation Conjugation of ligand to immobilized protein in organic solvent
US5962291A (en) * 1996-04-19 1999-10-05 The Regents Of The University Of Colorado Metal dependent catalytic antibodies and method for producing the same
WO1998008099A1 (en) * 1996-08-19 1998-02-26 SHAKER, Ghassan, I. Use of molt4 cd69 expression to determine the presence and activity of interferon inhibitors
US6190923B1 (en) 1997-09-05 2001-02-20 David K. Johnson Diethylenetriamine-N,N′,N″-triacetic acid derivatives
US7405320B2 (en) 1998-06-22 2008-07-29 Immunomedics, Inc. Therapeutic and diagnostic conjugates for use with multispecific antibodies
US7138103B2 (en) * 1998-06-22 2006-11-21 Immunomedics, Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy
US7833528B2 (en) * 1998-06-22 2010-11-16 Immunomedics, Inc. Use of multispecific, non-covalent complexes for targeted delivery of therapeutics
US6962702B2 (en) * 1998-06-22 2005-11-08 Immunomedics Inc. Production and use of novel peptide-based agents for use with bi-specific antibodies
US7387772B1 (en) * 1999-06-22 2008-06-17 Immunimedics, Inc. Chimeric, human and humanized anti-CSAP monoclonal antibodies
AU760854B2 (en) * 1998-06-22 2003-05-22 Immunomedics Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy
US20030215359A1 (en) * 1998-10-02 2003-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US6475743B1 (en) 1998-10-02 2002-11-05 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US7449338B2 (en) * 1998-10-02 2008-11-11 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US7297544B2 (en) 1998-10-02 2007-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US7070937B1 (en) 1998-10-02 2006-07-04 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US20050142613A1 (en) * 1998-10-02 2005-06-30 David Bar-Or Test for the rapid evaluation of ischemic states and kits
US20020199218A1 (en) * 1999-08-19 2002-12-26 Daphne Goring Proline-rich extensin-like receptor kinases
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
US7632803B2 (en) * 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
CA2364983A1 (en) * 2000-12-13 2002-06-13 John R. Coleman Nucleic acid molecules and polypeptides for catabolism of abscisic acid
WO2002048675A2 (en) * 2000-12-15 2002-06-20 Transderm Technologies, Llc Improved compositions and methods for producing antibodies to low molecular weight analytes
US7597895B2 (en) * 2001-02-20 2009-10-06 The Governing Council Of The University Of Toronto Signal peptides, nucleic acid molecules and methods for treatment of caries
US7556807B2 (en) 2001-02-20 2009-07-07 Kane Biotech, Inc. Signal peptides, nucleic acid molecules and methods for treatment of caries
US6686202B2 (en) * 2001-08-08 2004-02-03 Placer Dome, Inc. Methods for detecting and extracting gold
US20050049201A1 (en) * 2001-12-11 2005-03-03 Lowe Adrian M. Detection and removal of lead using lead-binding proteins
KR100923828B1 (ko) * 2004-03-31 2009-10-27 캐논 가부시끼가이샤 금-결합성 단백질
US8021849B2 (en) * 2004-11-05 2011-09-20 Siemens Healthcare Diagnostics Inc. Methods and kits for the determination of sirolimus in a sample
US7189582B2 (en) * 2005-04-27 2007-03-13 Dade Behring Inc. Compositions and methods for detection of sirolimus
WO2008134077A1 (en) * 2007-04-30 2008-11-06 Archemix Corp. Metabolic profile directed aptamer medicinal chemistry
CA2766272C (en) 2009-06-26 2021-02-09 Soricimed Biopharma Inc. Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery
CN113801220B (zh) * 2021-09-18 2023-07-07 青岛普瑞邦生物工程有限公司 一种米酵菌酸复合抗原、米酵菌酸抗体及其制备方法和酶联免疫试剂盒
CN114014934B (zh) * 2021-10-14 2023-05-05 江苏省农业科学院 多氯联苯单克隆抗体及其应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5599072A (en) * 1979-01-24 1980-07-28 Mitsubishi Petrochem Co Ltd Production of artificial antigen containing choline residue
US4281065A (en) * 1979-01-25 1981-07-28 Syva Company Phencyclidine conjugates to antigenic proteins and enzymes
US4261974A (en) * 1979-11-13 1981-04-14 Miles Laboratories, Inc. Valproic acid immunogen conjugates and antibodies thereto
JPS5714748A (en) * 1980-07-01 1982-01-26 Dainippon Pharmaceut Co Ltd Kit for quantitative determination of valproic acid and its method for quantitative determination
US4608337A (en) * 1980-11-07 1986-08-26 The Wistar Institute Human hybridomas and the production of human monoclonal antibodies by human hybridomas
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
JPS5838860A (ja) * 1981-08-31 1983-03-07 Dainippon Pharmaceut Co Ltd バルプロ酸の定量に用いるキツト及びその方法
US4681782A (en) * 1982-03-31 1987-07-21 Biostar Medical Products, Inc. Article for determining the presence of immune complexes
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
GB2131830A (en) * 1982-12-10 1984-06-27 Ludwig Inst Cancer Res Monoclonal antibody for use against breast cancer
US4456691A (en) * 1983-02-28 1984-06-26 Suad Stark Antigen for PCB, antibody raised by same, and method of making same
US4778752A (en) * 1983-10-11 1988-10-18 Scripps Clinic And Research Foundation Receptors specific for hapten-modified self proteins
FR2557458B1 (fr) * 1983-12-30 1987-09-04 Centre Nat Rech Scient Nouveaux anticorps capables de reconnaitre specifiquement des groupements hapteniques, leur preparation et leur application, et nouveaux antigenes permettant de les preparer
US4701408A (en) * 1984-01-30 1987-10-20 Smithkline Beckman Corporation Monoclonal antibody to activated macrophages
FR2561660B1 (fr) * 1984-03-26 1986-07-25 Centre Nat Rech Scient Nouveaux anticorps diriges contre un groupement haptenique contenant un motif choline, leur preparation et leur application, et nouveaux antigenes permettant de les preparer
US4764359A (en) * 1984-05-25 1988-08-16 Lemelson Jerome H Drug compositions and their use in treating human or other mammalian patients
EP0169645A1 (en) * 1984-06-27 1986-01-29 Johnson Matthey Public Limited Company Platinum co-ordination compounds
EP0167310B1 (en) * 1984-06-27 1991-05-29 Johnson Matthey Public Limited Company Platinum co-ordination compounds
CA1260827A (en) * 1984-08-31 1989-09-26 Richard C. Siegel Antibody-metal ion complexes
US4722892A (en) * 1984-08-31 1988-02-02 Meares Claude F Monoclonal antibodies against metal chelates
US4530786A (en) * 1984-09-04 1985-07-23 Colorado State University Research Foundation Antibody for the detection and quantification of atrazine
JPS63501096A (ja) * 1984-10-29 1988-04-21 エクス インコ−ポレ−テツド 小型分子の免疫測定法
JPS61145200A (ja) * 1984-12-19 1986-07-02 Snow Brand Milk Prod Co Ltd ウシラクトフェリンの分離精製法
EP0194158A3 (en) * 1985-03-08 1988-02-24 Baylor College of Medicine Anti-nicotine and anti-cotinine antibodies (monoclonal and other), and their uses in nicotine and cotinine assays
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
DE3515901A1 (de) * 1985-05-03 1986-11-06 Battelle-Institut E.V., 6000 Frankfurt Verfahren zum nachweis von 1, 2, 2-trimethylpropylmethylphosphofluoridad
CA1302919C (en) * 1985-07-03 1992-06-09 Robert T. Buckler Histamine derivatives, immunogen conjugates and antibodies raised thereto
JPS6251699A (ja) * 1985-08-30 1987-03-06 Nichirei:Kk 単クロ−ン性抗体およびそれを用いる測定法
GB8530829D0 (en) * 1985-12-13 1986-01-22 Syngene International Nv Monoclonal antibodies
US4772551A (en) * 1985-12-26 1988-09-20 Neogen Corporation Method and test kit for detecting a trichothecene using novel monoclonal antibodies
US4797473A (en) * 1986-06-25 1989-01-10 Regents Of The University Of Minnesota Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins
DE3632343A1 (de) * 1986-09-24 1988-04-07 Battelle Institut E V Verfahren zum nachweis von 1,2,2-trimethylpropylmethylphosphofluoridad
US4859613A (en) * 1986-11-12 1989-08-22 Lawrence David A Immunoassays for glutathione and antibodies useful therein
US4793986A (en) * 1987-02-25 1988-12-27 Johnson Matthey, Inc. Macromolecular platinum antitumor compounds
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides

Also Published As

Publication number Publication date
DE69031909T2 (de) 1998-04-16
CA2047717C (en) 2000-08-01
ATE161852T1 (de) 1998-01-15
AU648022B2 (en) 1994-04-14
US5503987A (en) 1996-04-02
JPH05504464A (ja) 1993-07-15
CA2047717A1 (en) 1990-09-15
WO1990010709A3 (en) 1990-11-15
EP0463110B1 (en) 1998-01-07
FI100472B (fi) 1997-12-15
WO1990010709A2 (en) 1990-09-20
EP0589487A1 (en) 1994-03-30
EP0463110A1 (en) 1992-01-02
AU5411490A (en) 1990-10-09
DE69031909D1 (de) 1998-02-12

Similar Documents

Publication Publication Date Title
FI914298A0 (fi) Monoklonala motkroppar foer metall- katjoner och smao molekyler.
DE69121844D1 (de) Immunotest für Cyclosporin
PT690675E (pt) Acido nucleico que codifica um percursor de antigenio de rejeicao de tumor
DE69223641T2 (de) Stabilisierte antikörper
ES8506902A1 (es) Un procedimiento para la purificacion de un antigeno.
DE68924850D1 (de) Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
DE59208982D1 (de) Verfahren zur Reinigung von IgG-monoklonalen Antikörpern
NO172596C (no) Apolipoprotein b-spesifikke monoklonale antistoffer produsert av to nye hybridomer, anvendelse av disse og diagnostiske systemer inneholdende disse
FI925321A (fi) Immunodiagnostiskt ledinflammationstest
CA2117536A1 (en) Immunological detection of organophosphates
YU46858B (sh) Postupak za dobijanje imunoglobulinskih konjugata
FI931581A (fi) Immunanalys, monoklonal antikropp och hybridom
BR9204982A (pt) Processo para a preparacao de um anticorpo,anticorpo monoclonal,linha de celulas de hibridoma,mutantes,processo e agente para a comprovacao imunologica,componente de copulaao e emprego
KR930004476A (ko) 인자(xiii)의 정제방법, 인자(xiiia)에 대한 모노클로날 항체, 이의 제조방법 및 용도
KR910006712A (ko) 형광편광기술에 사용하기 위한 모노클로날 항체의 안정화
PH21459A (en) Process for assaying atl virus antibody and reagent therefor
FI860937A (fi) Menetelmä ja reagenssi follikkelia stimuloivan hormonin määrittämiseksi sekä tähän tarkoitukseen sopivat monoklonaaliset vasta-aineet
ATE113935T1 (de) Radioaktive jodverbindung zur markierung von antikörpern.
MY104917A (en) Monoclonal antibodies and methods for diagnosis of phytophora infection
ATE110786T1 (de) Monoklonaler antikörper gegen exotoxin a von pseudomonas aeruginosa.
EP0373508A3 (en) Barbiturate assay, tracers, immunogens and antibodies
KR860000561A (ko) 시알리레이티드 루이스^x항원의 검출법
EP0184120A3 (en) Tracers for disopyramide assay and immunogens to raise antibody
EA199801011A1 (ru) Моноклональное антитело против человеческого мр52
FR2689246B1 (fr) Procede immunochimique de detection de l'origine d'une substance produite par genie genetique et reactifs pour sa mise en óoeuvre.